Alopecia Areata Universalis After Phenobarbital-Induced Anti-Convulsant Hypersensitivity Syndrome

REFERENCES

• Assouly P., Reygagne P., Jouanique C., Matard B., Marechal E., Reynert P., Bachelez H., Dubertret L. [Intravenous pulse methylprednisolone therapy for severe alopecia areata: an open study of 66 patients]. Ann. Dermatol. Venereol. 2003; 130(3)326–330
   Google Scholar
• Bavdekar S. B., Muranjan M. N., Gogtay N. J., Kantharia V., Kshirsagar N. A. Anticonvulsant hypersensitivity syndrome: lymphocyte toxicity assay for the confirmation of diagnosis and risk assessment. Ann. Pharmacother. 2004; 38(10)1648–1650
   PubMed Web of Science ®Google Scholar
• Bohan K. H., Mansuri T. F., Wilson N. M. Anticonvulsant hypersensitivity syndrome: implications for pharmaceutical care. Pharmacotherapy 2007; 27(10)1425–1439
   Google Scholar
• Chung W. H., Hung S. I., Hong H. S., Hsih M. S., Yang L. C., Ho H. C., Wu J. Y., Chen Y. T. Medical genetics: a marker for Stevens-Johnson syndrome. Nature 2004; 428(6982)486
   PubMed Web of Science ®Google Scholar
• Donati F., Gobbi G., Campistol J., Rapatz G., Daehler M., Sturm Y., Aldenkamp A. P. The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures. Seizure 2007; 16(8)670–679
   Google Scholar
• Fiedler V. C., Wendrow A., Szpunar G. J., Metzler C., DeVillez R. L. Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin. Arch. Dermatol. 1990; 126(6)756–759
   PubMedGoogle Scholar
• Friedli A., Labarthe M. P., Engelhardt E., Feldmann R., Salomon D., Saurat J. H. Pulse methylprednisolone therapy for severe alopecia areata: an open prospective study of 45 patients. J. Am. Acad. Dermatol. 1998; 39(4 Pt 1)597–602
   PubMedGoogle Scholar
• Gaedigk A., Spielberg S. P., Grant D. M. Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions. Pharmacogenetics 1994; 4(3)142–153
   PubMedGoogle Scholar
• Gennis M. A., Vemuri R., Burns E. A., Hill J. V., Miller M. A., Spielberg S. P. Familial occurrence of hypersensitivity to phenytoin. Am. J. Med. 1991; 91(6)631–634
   PubMed Web of Science ®Google Scholar
• Gilhar A., Kam Y., Assy B., Kalish R. S. Alopecia areata induced in C3H/HeJ mice by interferon-gamma: evidence for loss of immune privilege. J. Invest. Dermatol. 2005; 124(1)288–289
   PubMed Web of Science ®Google Scholar
• Gilhar A., Paus R., Kalish R. S. Lymphocytes, neuropeptides, and genes involved in alopecia areata. J. Clin. Invest. 2007; 117(8)2019–2027
   PubMed Web of Science ®Google Scholar
• Hillemacher T., Bleich S., Kornhuber J., Frieling H. Hair loss as a side effect of lamotrigine treatment. Am. J. Psych. 2006; 163(8)1451
   Google Scholar
• Ito T., Ito N., Saathoff M., Bettermann A., Takigawa M., Paus R. Interferon-gamma is a potent inducer of catagen-like changes in cultured human anagen hair follicles. Br. J. Dermatol. 2005; 152(4)623–631
   PubMed Web of Science ®Google Scholar
• Kano Y., Shiohara T. Sequential reactivation of herpesvirus in drug-induced hypersensitivity syndrome. Acta Derm. Venereol. 2004; 84(6)484–485
   Google Scholar
• Kavak A., Baykal C., Ozarmagan G., Akar U. HLA in alopecia areata. Int. J. Dermatol. 2000; 39(8)589–592
   PubMed Web of Science ®Google Scholar
• Knowles S. R., Shapiro L. E., Shear N. H. Anticonvulsant hypersensitivity syndrome: incidence, prevention and management. Drug Saf. 1999; 21(6)489–501
   PubMed Web of Science ®Google Scholar
• Knutsen A. P., Shah M., Schwarz K. B., Tsai C. C. Graft versus host-like illness in a child with phenobarbital hypersensitivity. Pediatrics 1986; 78(4)581–584
   Google Scholar
• Kocer A., Sasmaz S., Ince N., Kutlar M., Cagirici S. Skin findings related to chronic usage of anti-epileptic drugs. Saudi Med. J. 2005; 26(8)1216–1219
   Google Scholar
• Kohno Y., Ishii A., Shoji S. [A case of hair loss induced by carbamazepine]. Rinsho Shinkeigaku 2004; 44(6)379–381
   Google Scholar
• Krauss G. Current understanding of delayed anticonvulsant hypersensitivity reactions. Epilepsy Curr. 2006; 6(2)33–37
   PubMedGoogle Scholar
• Lee W. I., Kuo M. L., Huang J. L., Lin S. J., Wu C. J. Distribution and clinical aspects of primary immunodeficiencies in a Taiwan pediatric tertiary hospital during a 20-year period. J. Clin. Immunol. 2005; 25(2)162–173
   Google Scholar
• Lortkipanidze N. T., Tevzadze M., Kamkamidze G. K. [Interferon-gamma and neopterin in alopecia areata]. Georgian Med. News 2005, 123: 53–57
   Google Scholar
• Mangalvedhekar S. S., Gogtay N. J., Manjula S., Kadam V. S., Dalvi S. S., Shah P. U., Badakere S. S., Pradhan V. D., Kshirsagar N. A. Phenytoin associated alopecia: drug induced lupus. J. Assoc. Phys, India 2001; 49: 929–930
   PubMedGoogle Scholar
• McDonagh A. J., Messenger A. G. The pathogenesis of alopecia areata. Dermatol. Clin. 1996; 14(4)661–670
   PubMed Web of Science ®Google Scholar
• McDonagh A. J., Tazi-Ahnini R. Epidemiology and genetics of alopecia areata. Clin. Exp. Dermatol. 2002; 27(5)405–409
   PubMed Web of Science ®Google Scholar
• Morkunas A. R., Miller M. B. Anticonvulsant hypersensitivity syndrome. Crit. Care Clin. 1997; 13(4)727–739
   PubMed Web of Science ®Google Scholar
• Olsen E. A., Carson S. C., Turney E. A. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. Arch. Dermatol. 1992; 128(11)1467–1473
   PubMedGoogle Scholar
• Oskay T., Karademir A., Erturk O. I. Association of anticonvulsant hypersensitivity syndrome with Herpesvirus 6, 7. Epilepsy Res 2006; 70(1)27–40
   Google Scholar
• Patrizi A., Savoia F., Negosanti F., Posar A., Santucci M., Neri I. Telogen effluvium caused by magnesium valproate and lamotrigine. Acta Derm. Venereol. 2005; 85(1)77–78
   PubMedGoogle Scholar
• Paus R., Nickoloff B. J., Ito T. A ‘hairy’ privilege. Trends Immunol. 2005; 26(1)32–40
   PubMed Web of Science ®Google Scholar
• Paus R., Slominski A., Czarnetzki B. M. Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb?. Yale J. Biol. Med. 1993; 66(6)541–554
   PubMed Web of Science ®Google Scholar
• Pichler W. J. Delayed drug hypersensitivity reactions. Ann. Intern. Med. 2003; 139(8)683–693
   PubMed Web of Science ®Google Scholar
• Ranchoff R. E., Bergfeld W. F., Steck W. D., Subichin S. J. Extensive alopecia areata. Results of treatment with 3% topical minoxidil. Cleve. Clin. J. Med. 1989; 56(2)149–154
   Google Scholar
• Schulpis K. H., Karikas G. A., Tjamouranis J., Regoutas S., Tsakiris S. Low serum biotinidase activity in children with valproic acid monotherapy. Epilepsia 2001; 42(10)1359–1362
   PubMed Web of Science ®Google Scholar
• Sharma V. K., Kumar B., Dawn G. A clinical study of childhood alopecia areata in Chandigarh, India. Pediatr. Dermatol. 1996; 13(5)372–377
   PubMed Web of Science ®Google Scholar
• Shear N. H., Spielberg S. P. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J. Clin. Invest. 1988; 82(6)1826–1832
   PubMed Web of Science ®Google Scholar
• Shohat M., Mimouni D., Ben-Amitai D., Sredni B., Sredni D., Shohat B., David M. In vitro cytokine profile in childhood alopecia areata and the immunomodulatory effects of AS-101. Clin. Exp. Dermatol. 2005; 30(4)432–434
   Google Scholar
• Shuper A., Stahl B., Weitz R. Carbamazepine-induced hair loss. Drug Intell. Clin. Pharm. 1985; 19(12)924–925
   Google Scholar
• Sundberg J. P., Boggess D., Silva K. A., McElwee K. J., King L. E., Li R., Churchill G., Cox G. A. Major locus on mouse chromosome 17 and minor locus on chromosome 9 are linked with alopecia areata in C3H/HeJ mice. J. Invest. Dermatol. 2003; 120(5)771–775
   PubMed Web of Science ®Google Scholar
• Sundberg J. P., Silva K. A., Li R., Cox G. A., King L. E. Adult-onset Alopecia areata is a complex polygenic trait in the C3H/HeJ mouse model. J. Invest. Dermatol. 2004; 123(2)294–297
   PubMed Web of Science ®Google Scholar
• Tanyasiri K., Hira K., Mitsuishi K., Ueki R., Sekigawa I., Ogawa H. Interleukin-16 in patients with alopecia areata. J. Dermatol. Sci. 2005; 37(1)55–57
   Google Scholar
• Tosti A., Bellavista S., Iorizzo M. Alopecia areata: a long term follow-up study of 191 patients. J. Am. Acad. Dermatol. 2006; 55(3)438–441
   PubMed Web of Science ®Google Scholar
• Verrotti A., Trotta D., Salladini C., Chiarelli F. Anticonvulsant hypersensitivity syndrome in children: incidence, prevention and management. CNS Drugs 2002; 16(3)197–205
   Google Scholar
• Wallace S. J. A comparative review of the adverse effects of anticonvulsants in children with epilepsy. Drug Saf. 1996; 15(6)378–393
   PubMed Web of Science ®Google Scholar
• Wasserman D., Guzman-Sanchez D. A., Scott K., McMichael A. Alopecia areata. Int. J. Dermatol. 2007; 46(2)121–131
   PubMedGoogle Scholar
• Welsh E. A., Clark H. H., Epstein S. Z., Reveille J. D., Duvic M. Human leukocyte antigen-DQB1*03 alleles are associated with alopecia areata. J. Invest. Dermatol. 1994; 103(6)758–763
   Google Scholar
• Xiao F. L., Ye D. Q., Yang S., Zhou F. S., Zhou S. M., Zhu Y. G., Liang Y. H., Ren Y. Q., Zhang X. J. Association of HLA haplotype with alopecia areata in Chinese Hans. J. Eur. Acad. Dermatol. Venereol. 2006; 20(10)1207–1213
   PubMed Web of Science ®Google Scholar
• Zoller M., McElwee K. J., Engel P., Hoffmann R. Transient CD44 variant isoform expression and reduction in CD4(+)/CD25(+) regulatory T cells in C3H/HeJ mice with alopecia areata. J. Invest. Dermatol. 2002; 118(6)983–992
   PubMed Web of Science ®Google Scholar